Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
American Journal of Cancer Research
|
October 11, 2023
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer
Chien-Yu Lin, Yun-Tse Chou, Po-Lan Su, et al.
Clinical Medicine Insights. Oncology
|
July 8, 2025
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study
I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, et al.
ACS Nano
|
February 18, 2025
Enhancing Lung Recovery: Inhaled Poly(lactic-<i>co</i>-glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
Huei-Han Zhang, Wen-Shuo Kuo, Pei-Yu Tu, et al.
American Journal of Cancer Research
|
August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)
Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Therapeutic Advances in Medical Oncology
|
March 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study
Qi-An Wang, I-Lin Tsai, Chien-Yu Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2025
CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression
Natalie Johns, Alexander Rudich, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches
Alexander Rudich, Natalie Johns, Songzhu Zhao, et al.
Journal of Fungi (Basel, Switzerland)
|
January 20, 2022
Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019
Chi-Jung Wu, Cong-Tat Cia, Hsuan-Chen Wang, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer
Xiaoying Wang, Maoteng Duan, Po-Lan Su, et al.
Scientific Reports
|
March 9, 2023
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
American Journal of Cancer Research
|
October 11, 2023
Generation and validation of a predictive model for estimating survival among patients with EGFR-mutant non-small cell lung cancer
Chien-Yu Lin, Yun-Tse Chou, Po-Lan Su, et al.
Clinical Medicine Insights. Oncology
|
July 8, 2025
Real-World Efficacy and Safety of S-1 Monotherapy in Non-Small Cell Lung Cancer Management: Insights From a Multicenter Retrospective Cohort Study
I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, et al.
ACS Nano
|
February 18, 2025
Enhancing Lung Recovery: Inhaled Poly(lactic-<i>co</i>-glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
Huei-Han Zhang, Wen-Shuo Kuo, Pei-Yu Tu, et al.
American Journal of Cancer Research
|
August 10, 2023
T790M detection rate after first-line combination therapy with bevacizumab and EGFR-TKIs in advanced NSCLC (TERRA Study)
Chih-Hsi Scott Kuo, Po-Lan Su, Yu-Feng Wei, et al.
Therapeutic Advances in Medical Oncology
|
March 17, 2025
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study
Qi-An Wang, I-Lin Tsai, Chien-Yu Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2025
CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression
Natalie Johns, Alexander Rudich, Songzhu Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 28, 2025
CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches
Alexander Rudich, Natalie Johns, Songzhu Zhao, et al.
Journal of Fungi (Basel, Switzerland)
|
January 20, 2022
Clinical and Microbiological Characteristics of Culture-Positive, Influenza-Associated Pulmonary Aspergillosis: A Single-Center Study in Southern Taiwan, 2016-2019
Chi-Jung Wu, Cong-Tat Cia, Hsuan-Chen Wang, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer
Xiaoying Wang, Maoteng Duan, Po-Lan Su, et al.
Scientific Reports
|
March 9, 2023
Effect of BIM expression on the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, et al.
Page
of 7